Insider · CIK 0001709603
Manuel Aivado
Files at RNTX (Aileron Therapeutics, Inc.). First filing -, latest -.
In brief
Manuel Aivado files SEC Form 4 as director at RNTX (Aileron Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Manuel Aivado has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | RNTX Aileron Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,500 | $0.00 | $0 | 17,500 | Jul 23, 2025 |
| Dec 2, 2024 | RNTX Aileron Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Dec 6, 2024 |
Questions about Manuel Aivado
Answered from the filings on this page, as of the latest one.
Is Manuel Aivado buying or selling?
Manuel Aivado has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Manuel Aivado's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Manuel Aivado has 0.
Where does Manuel Aivado file Form 4?
Manuel Aivado has filed Form 4 at RNTX (Aileron Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.